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ABSTRACT
Surveillance of healthcare-associated infections (HCAIs) makes evident the importance of the quality of
patient care, and the increasing demand for public reporting of HCAI surveillance data and related
quality indicators is thus not surprising. However, there is little evidence that public reporting results in
improved patient care. Debate continues about which HCAI-related indicators are the best measures of
performance and thus the most appropriate for public reporting. Suitable indicators should allow
improvements leading to better patient outcomes, and should be comparable among hospitals and
countries. Appropriate examples include central vascular catheter infections, surgical prophylaxis and
surgical site infections.
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Healthcare-associated infections (HCAIs) should
be considered as adverse events arising from
speciﬁc interventions or arising during residence
in acute-care hospitals and other healthcare
settings, e.g. nursing homes. Studies indicate that
5–10% of patients admitted to an acute-care
hospital develop an HCAI; Harbarth and col-
leagues have suggested that 10–70% of these are
preventable [1].
Increasingly, surveillance systems are making
evident the importance of quality and the way in
which surveillance data can reﬂect the level of
safety, or the absence of safety, in patient care [2].
For example, the introduction of a quality initia-
tive involving multidisciplinary ward rounds,
daily meetings to assess bed availability, the
implementation of healthcare bundles and culture
changes, in a combined medical and surgical
intensive care unit (ICU), resulted in reduced ICU
stay, decreased rates of ventilator-associated
pneumonia (VAP) and fewer other adverse events
[3]. Similar improvements in outcome have been
demonstrated with initiatives targeting antibiotic
prophylaxis in surgical centres [4] and prudent
antibiotic prescribing practice in hospitals [5].
A multidisciplinary initiative resulted in a reduc-
tion in HCAIs, including infections caused by
methicillin-resistant Staphylococcus aureus, and
this was associated with an increase in the use
of alcohol-based hand disinfectants [6]. Likewise,
improvements in hand hygiene practice, in con-
junction with other interventions, e.g. reducing
the duration of and choosing the correct site
for intravascular catheterization, in the form of
healthcare bundles, signiﬁcantly reduced cathe-
ter-related bloodstream infections in the ICU [7].
Given the impact of surveillance and patient
safety initiatives, it is not surprising that there is
an increasing demand for public reporting of
surveillance data concerning HCAIs and related
quality indicators. It is often assumed that public
reporting of such data will serve as an incentive
for hospitals to reduce rates of HCAI, but there is
little evidence to support this assumption [8].
A systematic review, on behalf of the Healthcare
Infection Control Practices Advisory Committee,
USA, found inconclusive evidence of the effec-
tiveness of public reporting in improving health-
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care, but no study investigated reductions in
HCAI as an outcome of public reporting [9]. A
more recent systematic review did not demon-
strate improvements in clinical outcomes associ-
ated with the publication of patient care
performance data, but did ﬁnd an association
with increased quality improvement measures in
hospitals [10]. Potential disadvantages of the
public disclosure of patient care performance
data have been reported, however, including an
inappropriate focus on what is being assessed
[11], and the avoidance of invasive procedures in
high-risk patients where they may have been
warranted [10].
Another rationale for the public reporting of
rates of HCAIs and performance indicators is to
inform consumer choice. In the USA, a number of
states have introduced mandatory public report-
ing of such data, based on the model Hospital
Infection Disclosure Act, developed by the Con-
sumers Union (http://www.consumersunion.
org). There is, however, little evidence that
patients, as consumers, use such data to make
informed choices about accessing healthcare [12].
Despite the lack of evidence of effectiveness,
many agree that the public have a right to
information on HCAIs and related quality indi-
cators. It is important, however, that this
information is meaningful and appropriate. Fur-
thermore, the provision of quality indicators
concerning HCAIs should be underpinned by
microbiology laboratories that can avail them-
selves of new technologies and laboratory-based
reporting systems [13].
The HCAI reporting systems mandated by state
legislatures in the USA have been criticized as
being costly, with considerable resources being
dedicated to hospital-wide surveillance, and the
collection of data on non-preventable HCAIs [14].
Other jurisdictions have attempted to report more
meaningful data to clinicians, health system
managers and the public. In France a ‘composite
indicator’, based on 31 process and outcome
indicators that include infection prevention and
control resources, provides a percentage score,
and is used for public reporting of HCAI-related
data (http://www.sante.gouv.fr). In the UK, indi-
vidual hospitals are assessed using a ‘balanced
scorecard’ with colour coding to summarize the
level of compliance with elements of the ‘Saving
Lives’ programme (UK Department of Health,
http://www.dh.gov.uk).
There is still considerable debate about which
HCAI-related indicators are the most appropriate
measures of healthcare performance and thus the
most appropriate for publication. To date, most of
these relate to acute-care hospitals and not neces-
sarily to other healthcare settings. In 2004, the
Institute for Healthcare Improvement in the USA
launched the 100 000 Lives Campaign, an initia-
tive to save lives in hospitals through improve-
ments in patient safety [15]. Three of the six
initiatives relate to the prevention of infection, i.e.
central-line infections, surgical site infections
(SSIs) and VAP [15]. The Surgical Care Improve-
ment Project, USA, has identiﬁed four areas that
require improvement, two of which relate to
infection, i.e. SSIs and the prevention of respira-
tory complications [16]. Klompas and Platt argue,
however, that VAP is inappropriate because of
difﬁculties in conﬁrming the diagnosis and
because even the CDC deﬁnitions of VAP are
relatively subjective [17]. Similarly, where there is
more than one set of quality parameters, there can
be confusion about how best to comply. Fong
et al. compared three sets of healthcare bundles
for severe sepsis, and investigated the factors
inﬂuencing variability in compliance rates [18].
Compliance with 50% or more of the quality
indicators was more likely to occur when patients
were in shock, when patients had an APACHE II
score ‡25, when two or more organs were failing
in a patient, and when patients survived hospi-
talization [18]. There needs to be clarity in
identifying the parameters that are important
when reporting quality indicators, and these
should reﬂect the measures most likely to beneﬁt
patient care.
Most surveillance systems do have an impact
on rates of HCAI and, despite the lack of evidence
showing that the public release of data results in
lower infection rates, it is likely that there will be
increasing demands for such public release. Con-
sequently, when national and other bodies are
considering which performance indicators to
publish, they should choose meaningful parame-
ters that can be compared among hospitals and
countries, and parameters that are likely to allow
improvements resulting in better patient out-
comes, e.g. those concerning central vascular
catheter infections, surgical prophylaxis and SSIs
[9]. There is a need for national and European
consensus on which data are most important, and
how such data can be collected, to improve the
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quality of care and to facilitate benchmarking
among countries. The decrease in rates of meth-
icillin-resistant Staphylococcus aureus bloodstream
infection seen in Slovenia and France, as recorded
in the European Antimicrobial Resistance Sur-
veillance System, illustrates how benchmarking
among countries can contribute to improvements.
European agencies should be mindful of the
potential impact that such initiatives can have
and not hesitate in taking initiatives.
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